CLINICAL_TRIALS trial_result · 2013-01-09

Clinical Trial Update: A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM) [Phase 2]

A 12-week Phase 2 clinical trial in patients with Type 2 Diabetes Mellitus has completed, sponsored by Novartis.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Novartis Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED